A Tumultuous Year for FDA: Perspectives and Predictions for 2026

2025 brought dramatic and disruptive change to FDA and the industries it regulates. Join Polsinelli's experienced FDA team and special guest, Wayne Pines, for a roundtable discussion to reflect on the most notable developments of 2025 and explore whether 2026 will bring further change. How should stakeholders adjust to the new realities at FDA

Agenda

• How New Policies Have Impacted the Oversight of Drugs, Biologics and Vaccines
• Food Policies in Transition: Synthetic Colors on the Way Out; GRAS is Next; Ultra Processed Foods Under Scrutiny
• FDA’s 2026 Agenda and How Stakeholders Should Prepare
• Litigation Developments and Potential Challenges in 2026